Education
About Us
Working with TipRanks
Follow Us
JTEC Corp. (Osaka) (JP:3446)
:3446
3446 Stock Chart & Stats
¥1190.00
-¥31.00(-2.12%)
At close: 4:00 PM EST
¥1190.00
-¥31.00(-2.12%)
Day’s Range― - ―
52-Week Range¥860.00 - ¥2,514.00
Previous CloseN/A
Volume78.70K
Average Volume (3M)93.54K
Market Cap
¥13.06B
Enterprise Value¥13.57B
Total Cash (Recent Filing)¥793.30M
Total Debt (Recent Filing)¥461.45M
Price to Earnings (P/E)―
Beta1.23
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,905,500
10 Day Avg. Volume57,320
30 Day Avg. Volume93,543
Financial Highlights & Ratios
PEG Ratio-1.75
Price to Book (P/B)2.65
Price to Sales (P/S)3.82
P/FCF Ratio40.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetLow leverage and a 75.3% equity ratio give JTEC durable financial flexibility versus peers in medical instruments. This foundation supports sustained R&D, working capital needs, or opportunistic M&A without stressing cash flow, helping the firm withstand industry cyclical shocks.
Improving Cash GenerationA large rise in free cash flow and strong cash-conversion ratios signal improving internal funding capacity. Over months, higher FCF reduces reliance on external capital, enables reinvestment in product development or capital expenditure, and increases resilience to revenue softness.
High Gross MarginA ~61% gross margin implies meaningful pricing power or manufacturing efficiency in medical instruments. Persistently high gross margins provide a structural cushion for profitability, allowing the company to absorb SG&A or R&D investment while retaining scope to restore net margins long-term.
Bears Say
Declining RevenueAn 11.4% drop in reported revenue growth indicates weakening demand or lost share in key markets. Over a multi-month horizon, persistent top-line contraction limits economies of scale, constrains reinvestment capacity, and raises execution risk for returning to sustained growth in medical devices.
Compressing Net MarginsA sharp fall in net margin to ~3.1% shows operating leverage erosion or rising non‑operating costs. Even with high gross margins, sustained margin compression reduces retained earnings and the firm's ability to fund strategic initiatives, increasing sensitivity to revenue shocks.
Falling EPSA >50% decline in EPS signals deteriorating bottom-line performance and weak profitability conversion. Over months, falling EPS can impair reinvestment, limit shareholder return options, and reflect structural pressure on margins or volumes rather than a short-lived fluctuation.
JTEC Corp. (Osaka) News
3446 FAQ
What was JTEC Corp. (Osaka)’s price range in the past 12 months?
JTEC Corp. (Osaka) lowest stock price was ¥860.00 and its highest was ¥2514.00 in the past 12 months.
What is JTEC Corp. (Osaka)’s market cap?
JTEC Corp. (Osaka)’s market cap is ¥13.06B.
When is JTEC Corp. (Osaka)’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were JTEC Corp. (Osaka)’s earnings last quarter?
Currently, no data Available
Is JTEC Corp. (Osaka) overvalued?
According to Wall Street analysts JTEC Corp. (Osaka)’s price is currently Overvalued.
Does JTEC Corp. (Osaka) pay dividends?
JTEC Corp. (Osaka) does not currently pay dividends.
What is JTEC Corp. (Osaka)’s EPS estimate?
JTEC Corp. (Osaka)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does JTEC Corp. (Osaka) have?
JTEC Corp. (Osaka) has 5,905,500 shares outstanding.
What happened to JTEC Corp. (Osaka)’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of JTEC Corp. (Osaka)?
Currently, no hedge funds are holding shares in JP:3446
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
JTEC Corp. (Osaka)
JTEC Corporation designs, manufactures, and sells X-ray mirrors for synchrotron facilities in Japan. Its X-ray mirrors are used for study in the pharmaceutical, electronic, material, food, beauty, and other fields. The company also designs, develops, manufactures, and sells automated cell culture systems, as well as automated systems in various fields. JTEC Corporation was founded in 1993 and is headquartered in Ibaraki, Japan.